Skip to main content
Premium Trial:

Request an Annual Quote

Merck Taps PPD as Preferred Provider for Proteomic Biomarker Discovery

NEW YORK, June 22 (GenomeWeb News) - PPD said yesterday that it has been selected as Merck's "preferred provider" for protein biomarker analysis.


Under the terms of the agreement, PPD will analyze Merck samples with its proprietary proteomic analysis platform to identify candidate biological markers for its therapeutic business.


Additional terms of the agreement were not disclosed.


A PPD spokeswoman told GenomeWeb News that the agreement has extended the collaboration to PPD following its acquisition of SurroMed in January, but the relationship with Merck is non-exclusive.


SurroMed had an ongoing collaboration with Merck for its biomarker discovery services. "We had a relationship and we're taking it one step further," the PPD spokesperson said.


PPD said that its technology can be used to analyze samples for novel or known biomarkers, in the presence or absence of a drug, in order to evaluate the efficacy of the drug.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.